NCT02506153
Clinical Trial Information
Trial Number: NCT02506153 (ClinicalTrials.gov)
Disease Type:
- Skin Neoplasm - Melanoma
Trial Title:
A Phase III Randomized Trail Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma
Study ID:
S1404
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®